Mélanome métastatique thérapies ciblées/immunothérapie

Mélanome métastatique
thérapies
ciblées/immunothérapie
Dr Jean Paul Salmon Pr Guy
Jerusalem
CHR Liège, le 09 mars 2017

Overall Survival Metastatic Melanoma<br />1-year OS Phase III Studies
Presented By Georgina Long at 2016 ASCO Annual Meeting

Overall Survival in Melanoma
Presented By Georgina Long at 2016 ASCO Annual Meeting

Two Paradigms for Advancing the Therapy of
Metastatic Melanoma
Target host
Target
tumor
Immunotherapy Targeted
Therapy
Ribas A.

Klik om het opmaakprofiel van de modelondertitel te
bewerken
Les traitements ciblés